Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sweden TA council sceptical about STAN claims for foetal monitoring

This article was originally published in Clinica

Executive Summary

There is limited scientific evidence to suggest that foetal monitoring during birth can be improved by using a STAN monitor, claims a recent report, published by the Swedish Council on Technology Assessment in Health Care (SBU). Furthermore, the report is sceptical about any potential healthcare economy benefits that could be gained by the use of this method STAN, which has been approved by the US FDA, combines standard cardiotocography (CTG) technology with the ST waveform analysis of the foetal electrocardiogram (ECG). Essentially, the combination of CTG and ST offers a more precise identification of foetuses suffering from a lack of oxygen and allows for accurate and consistent intervention. The method was developed by Neoventa Medical, a company that develops monitoring and management tools for improved perinatal healthcare. The company is based in Molndal, near Gothenburg, Sweden.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT052320

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel